5 Myths About Bioidentical Hormone Replacement Therapy

Available for Interviews: Dr. Karyn Eilber

Karyn Eilber, MD, is a board-certified urologist, an associate professor of urology & OB/GYN at Cedars-Sinai Hospital in Los Angeles, and is an expert in women’s health and men & women’s sexual wellness.

What Dr. Eilber Can Say on
Bioidentical Hormone Replacement Therapy:

Some women feel safer taking bioidentical hormones compared to prescription hormone replacement therapy because of the belief that they have fewer side effects such as the risk of cancer; however, the scientific data is lacking.

When it comes to bioidentical hormone replacement, here are 5 myths:

 1. Bioidentical hormone replacement therapy is a medical term. It’s just a term used by makers of BHRT but it is not recognized by the FDA. 

 2. It’s safer than traditional hormone replacement. They are not safer just because they are “natural.” There is no convincing data that bioidentical hormones are more or less safe compared to traditional hormone replacement therapy.

 3. Saliva tests for bioidentical hormone replacement therapy are accurate. The saliva isn’t as reliable as blood tests, but replacement should be based on the relief of a woman’s symptoms and not just saliva or blood levels of hormones.

 4. Bioidentical hormones don’t have as many side effects. Because bioidentical hormones are compounded at individual pharmacies, the side effects do not have to be reported as drugs that have gone through FDA approval.

 5. Doctors will only prescribe traditional OR bioidentical hormone replacement therapy. Many doctors who prescribe hormones will help you find which type of hormone replacement is right for you. 


Interview: Dr. Karyn Eilber

Karyn Eilber, MD, is a board-certified urologist with sub-specialty board certification in Female Pelvic Medicine and Reconstructive Surgery and has over 20 years of experience taking care of women’s most intimate needs. She is an Associate Professor of Urology and Obstetrics & Gynecology at Cedars-Sinai Medical Center and is the Associate Program Director for the Cedars-Sinai Urology Residency Training Program. Prior to joining Cedars-Sinai, Dr. Eilber served at the Memorial Sloan-Kettering Cancer Center’s Urology Department, where she gained extensive experience in pelvic reconstruction following cancer treatment.

​Dr. Eilber’s research focus has been in the field of urogynecology, and she has published multiple peer-reviewed manuscripts and book chapters. In addition to being a member and past president of the Los Angeles Urologic Society, Dr. Eilber is a member of the American Urological Association, the Society of Urodynamics, Female Pelvic Medicine & Urogenital reconstruction, the American Urogynecologic Society, and the Society of Women in Urology. She is also a Founding Medical Partner of Doctorpedia.

Dr. Eilber earned her bachelor’s degree in Biomedical Sciences from the University of California, Riverside, which was an accelerated 3-year premedical program that allowed her to matriculate into the University of California, Los Angeles School of Medicine (UCLA). She completed a general surgery internship, urology residency, and female pelvic medicine fellowship at UCLA. 

Jo Allison
Managing Editor
Director of Public Relations
Success In Media, Inc.

Leave a Reply